Domain Associates
API Closes on $28M Round Supporting Development of Colorectal Test, Biomarker Discovery Efforts
Premium
Applied Proteomics said this week that it has closed a $28 million Series C financing round.
In March 2010, Austin, Texas-based diagnostics firm Vermillion launched sales of its OVA1 ovarian cancer test.
Epic Sciences Raises $13M in Series B Round
NEW YORK (GenomeWeb News) – Epic Sciences today announced it has completed its Series B financing round raising $13 million.
Protein biomarker diagnostics firm Astute Medical this week said it had completed a Series C financing round that raised $40.4 million.
Feb 10, 2012
Mar 11, 2011